1.63
price down icon2.14%   -0.0356
after-market 시간 외 거래: 1.66 0.03 +1.84%
loading
전일 마감가:
$1.6656
열려 있는:
$1.66
하루 거래량:
16,716
Relative Volume:
0.17
시가총액:
$14.11M
수익:
$149.50K
순이익/손실:
$-6.96M
주가수익비율:
-1.1985
EPS:
-1.36
순현금흐름:
$-6.37M
1주 성능:
-4.61%
1개월 성능:
-7.12%
6개월 성능:
+13.99%
1년 성능:
-17.68%
1일 변동 폭
Value
$1.60
$1.67
1주일 범위
Value
$1.60
$1.72
52주 변동 폭
Value
$1.21
$2.55

Biorestorative Therapies Inc Stock (BRTX) Company Profile

Name
명칭
Biorestorative Therapies Inc
Name
전화
(631) 760-8100
Name
주소
40 MARCUS DRIVE, MELVILLE
Name
직원
11
Name
트위터
Name
다음 수익 날짜
2024-11-11
Name
최신 SEC 제출 서류
Name
BRTX's Discussions on Twitter

BRTX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
BRTX
Biorestorative Therapies Inc
1.63 14.11M 149.50K -6.96M -6.37M -1.36
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
452.16 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
534.91 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.06 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
542.47 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.16 28.51B 3.81B -644.79M -669.77M -6.24

Biorestorative Therapies Inc 주식(BRTX)의 최신 뉴스

pulisher
Jun 18, 2025

Transcript : BioRestorative Therapies, Inc.Special Call - MarketScreener

Jun 18, 2025
pulisher
Jun 18, 2025

BioRestorative CEO Reveals New BRTX-100 Clinical Data and Growth Strategy: Key Updates You Can't Miss Today - Stock Titan

Jun 18, 2025
pulisher
Jun 18, 2025

Stock Buyback Plan Declared by Biorestorative Therapies (NASDAQ:BRTX) - Defense World

Jun 18, 2025
pulisher
Jun 17, 2025

BioRestorative Therapies (BRTX) Initiates $2 Million Stock Buyba - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

BioRestorative Announces Share Repurchase Program - Ortho Spine News

Jun 17, 2025
pulisher
Jun 17, 2025

BioRestorative Therapies (BRTX) Initiates $2 Million Stock Buyback Program | BRTX Stock News - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

BioRestorative Therapies' Board Of Directors Authorizes Repurchase Of Up To $2 Mln Of Common Stock - Nasdaq

Jun 17, 2025
pulisher
Jun 17, 2025

BioRestorative Therapies, Inc. Announces $2 Million Stock Repurchase Program to Enhance Shareholder Value - Nasdaq

Jun 17, 2025
pulisher
Jun 17, 2025

BioRestorative CEO Signals Stock Undervalued, Announces $2M Share Repurchase Plan - Stock Titan

Jun 17, 2025
pulisher
Jun 13, 2025

BioRestorative Therapies (BRTX) Reports Promising Phase 2 Trial - GuruFocus

Jun 13, 2025
pulisher
Jun 13, 2025

BioRestorative Reports Compelling Preliminary Data for FDA-Fast-Tracked BRTX-100 – an Autologous Stem Cell Therapy to Treat Chronic Lumbar Disc Disease - Ortho Spine News

Jun 13, 2025
pulisher
Jun 13, 2025

Anchoring Your Portfolio: Is BRTX Stock a Safe Harbor? - investchronicle.com

Jun 13, 2025
pulisher
Jun 13, 2025

BioRestorative Reports Promising Phase 2 Trial Results - TipRanks

Jun 13, 2025
pulisher
Jun 13, 2025

BioRestorative Therapies Says BRTX-100 Improved Function in Phase 2 Chronic Lumbar Disc Disease Trial - marketscreener.com

Jun 13, 2025
pulisher
Jun 13, 2025

BioRestorative reports positive data from BRTX-100 stem cell therapy trial - Investing.com Nigeria

Jun 13, 2025
pulisher
Jun 13, 2025

BioRestorative Reports Compelling Preliminary Data For FDA-Fast-Tracked BRTX-100 - marketscreener.com

Jun 13, 2025
pulisher
Jun 13, 2025

BioRestorative Therapies, Inc. Reports Promising Phase 2 Clinical Trial Results for BRTX-100 at ISSCR 2025 Annual Meeting - Nasdaq

Jun 13, 2025
pulisher
Jun 13, 2025

Breakthrough Stem Cell Therapy BRTX-100 Achieves 74% Success Rate in Chronic Back Pain Trial - Stock Titan

Jun 13, 2025
pulisher
Jun 13, 2025

Citadel Advisors LLC Buys New Stake in BioRestorative Therapies, Inc. (NASDAQ:BRTX) - Defense World

Jun 13, 2025
pulisher
Jun 11, 2025

BioRestorative Therapies (OTCMKTS:BRTXQ) Trading 0.3% Higher – Still a Buy? - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

Stocks in play: ATCO Ltd. - The Globe and Mail

Jun 10, 2025
pulisher
Jun 10, 2025

BioRestorative Welcomes Serial Regenerative Medicine Entrepreneur, Company Builder and Leader, Sandy Lipkins, to BRTX Team - Barchart.com

Jun 10, 2025
pulisher
Jun 10, 2025

BRTX Appoints Sandy Lipkins for Strategic Expansion | BRTX Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

30-Year Regenerative Medicine Pioneer Joins BioRestorative to Lead Global Commercialization Strategy - Stock Titan

Jun 10, 2025
pulisher
Jun 10, 2025

BioRestorative Therapies (NASDAQ:BRTX) Shares Up 0.3% – Should You Buy? - Defense World

Jun 10, 2025
pulisher
Jun 09, 2025

BioRestorative to Present Major Update on Promising Preliminary Phase 2 BRTX-100 Data at ISSCR 2025 - The Globe and Mail

Jun 09, 2025
pulisher
Jun 09, 2025

BioRestorative Therapies to Present New Preliminary Clinical Data for BRTX-100 at ISSCR 2025 Annual Meeting - Nasdaq

Jun 09, 2025
pulisher
Jun 09, 2025

Major Phase 2 Clinical Trial Update: BRTX-100 Stem Cell Therapy Shows New Safety Data in 30 Back Pain Patients - Stock Titan

Jun 09, 2025
pulisher
May 24, 2025

BioRestorative Therapies Announces Closing of $23 Million Public Offering - The Globe and Mail

May 24, 2025
pulisher
May 20, 2025

BioRestorative Therapies (OTCMKTS:BRTXQ) Shares Down 3.6% – Should You Sell? - Defense World

May 20, 2025
pulisher
May 19, 2025

What is Roth Capital’s Estimate for BRTX Q2 Earnings? - Defense World

May 19, 2025
pulisher
May 16, 2025

BioRestorative Therapies, Inc. (NASDAQ:BRTX) Q1 2025 Earnings Call Transcript - Insider Monkey

May 16, 2025
pulisher
May 15, 2025

BioRestorative Therapies’ Earnings Call: Progress Amid Challenges - TipRanks

May 15, 2025
pulisher
May 15, 2025

Biorestorative Therapies, Inc. (BRTX) Reports Q1 Loss, Lags Revenue Estimates - MSN

May 15, 2025
pulisher
May 15, 2025

BioRestorative Therapies Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 15, 2025
pulisher
May 15, 2025

Earnings call transcript: BioRestorative Therapies Q1 2025 sees widened losses - Investing.com Nigeria

May 15, 2025
pulisher
May 15, 2025

BioRestorative Therapies Reports Q1 2025 Results and Updates - TipRanks

May 15, 2025
pulisher
May 14, 2025

BIORESTORATIVE THERAPIES Earnings Results: $BRTX Reports Quarterly Earnings - Nasdaq

May 14, 2025
pulisher
May 14, 2025

BioRestorative Therapies Reports First Quarter 2025 Financial Results and Provides Business Update - Ortho Spine News

May 14, 2025
pulisher
May 14, 2025

BioRestorative's Spine Treatment Gets FDA Fast Track After Positive 52-Week Trial Data - Stock Titan

May 14, 2025
pulisher
May 13, 2025

BioRestorative Therapies (BRTX) Reports Positive Initial Results in Phase 2 Trial | BRTX Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Phase 2 Trial of BRTX-100 in cLDD Continues to Generate Positive Preliminary Blinded Data - Ortho Spine News

May 13, 2025
pulisher
May 13, 2025

BioRestorative Therapies, Inc. Announces Positive Preliminary Data from Phase 2 Trial of BRTX-100 for Chronic Lumbar Disc Disease at ISCT 2025 Annual Meeting - Nasdaq

May 13, 2025
pulisher
May 13, 2025

BioRestorative Therapies (BRTX) to Release Quarterly Earnings on Wednesday - Defense World

May 13, 2025
pulisher
May 09, 2025

BioRestorative Therapies Inc expected to post a loss of 32 cents a shareEarnings Preview - TradingView

May 09, 2025
pulisher
May 08, 2025

BioRestorative Therapies to Report First Quarter 2025 Financial Results and Host Conference Call on May 14, 2025 - The Manila Times

May 08, 2025
pulisher
May 08, 2025

BioRestorative Therapies, Inc. to Release First Quarter 2025 Financial Results on May 14, 2025 - Nasdaq

May 08, 2025
pulisher
May 07, 2025

BioRestorative to Present a BRTX-100 Clinical Update at ISCT 2025 - The Manila Times

May 07, 2025
pulisher
May 06, 2025

BioRestorative To Present A BRTX-100 Clinical Update At ISCT 2025 - Barchart.com

May 06, 2025
pulisher
Apr 30, 2025

Reviewing BioRestorative Therapies (OTCMKTS:BRTX) and Silence Therapeutics (OTCMKTS:SLNCF) - Defense World

Apr 30, 2025
pulisher
Apr 26, 2025

BioRestorative Therapies (OTCMKTS:BRTXQ) Trading Down 2.3% – Here’s Why - Defense World

Apr 26, 2025

Biorestorative Therapies Inc (BRTX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$20.74
price up icon 0.39%
$35.88
price down icon 0.42%
$21.20
price down icon 0.38%
$97.62
price down icon 3.00%
$107.51
price up icon 0.98%
biotechnology ONC
$245.16
price up icon 1.28%
자본화:     |  볼륨(24시간):